Position in SYK
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,878,682
-$10,343,383 QoQ
Shares Held
63,139
-31.4% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#337
of 2,258 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in SYK Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026BRADLEY FOSTER & SARGENT INC/CT holds $87,877,885 across 9 Medical Devices names. SYK ranks #2 (22.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
593,845 | $53,885,495 | |
| 2 | SYK |
Stryker Corp
This page
|
63,139 | $19,878,682 | |
| 3 | GEHC |
GE HealthCare Technologies Inc.
|
84,197 | $5,389,449 | |
| 4 | BSX |
Boston Scientific Corp
|
69,510 | $2,966,686 | |
| 5 | MDT |
Medtronic plc
|
29,052 | $2,272,737 | |
| 6 | EW |
Edwards Lifesciences Corp
|
14,372 | $1,300,091 | |
| 7 | AXGN |
Axogen, Inc.
|
24,577 | $1,135,211 | |
| 8 | ZBH |
Zimmer Biomet Holdings, Inc.
|
6,250 | $538,062 |
All Filings in SYK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,878,682 | 63,139 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $30,222,065 | 91,975 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $33,873,272 | 96,376 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $33,396,727 | 90,342 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $34,408,336 | 86,971 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $22,790,261 | 61,223 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $21,721,456 | 60,329 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $21,187,899 | 58,650 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $19,696,392 | 57,888 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $20,743,576 | 57,964 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $17,621,424 | 58,844 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $15,966,073 | 58,426 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $17,825,188 | 58,426 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $16,290,345 | 57,065 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $13,828,354 | 56,560 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $29,672,312 | 146,501 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $32,278,779 | 162,262 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $45,546,013 | 170,361 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $45,742,191 | 171,050 | Shares | Sole | 2022-03-11 | |
| 2021-09-30 | $44,915,471 | 170,315 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $45,127,827 | 173,749 | Shares | Sole | 2021-08-19 | |
| 2021-03-31 | $42,157,852 | 173,076 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $42,702,140 | 174,266 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $36,513,925 | 175,236 | Shares | Sole | 2020-10-26 | |
| 2020-03-31 | $27,394,431 | 164,541 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||